Centre hospitalier de l'Université Laval merged in December 1995 with two other teaching hospitals to form Centre hospitalier universitaire de Québec: Hôtel-Dieu de Québec Hôpital Saint-François d'Assise

During the past decade, Centre Hospitalier Universitaire de Quebec conducted 210 clinical trials. In the 10-year time frame, 210 clinical trials started and 132 clinical trials were completed, i.e. on average, 62.9% percent of trials that started reached the finish line to date. In the past 5 years, 87 clinical trials started and 64 clinical trials were completed. i.e. 73.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier Universitaire de Quebec" #1 sponsor was "Children's Oncology Group" with 92 trials, followed by "CHU de Quebec-Universite Laval" with 33 trials sponsored, "Radiation Therapy Oncology Group" with 31 trials sponsored, "National Cancer Institute (NCI)" with 30 trials sponsored and "NCIC Clinical Trials Group" with 30 trials sponsored. Other sponsors include 230 different institutions and companies that sponsored additional 133 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Universitaire de Quebec" #1 collaborator was "National Cancer Institute (NCI)" with 142 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 27 trials as a collaborator, "CHU de Quebec-Universite Laval" with 16 trials as a collaborator, "Laval University" with 12 trials as a collaborator and "NCIC Clinical Trials Group" with 12 trials as a collaborator. Other collaborators include 370 different institutions and companies that were collaborators in the rest 253 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Universitaire de Quebec" are "Prostate Cancer" (22 trials), "Sarcoma" (14 trials), "Leukemia" (13 trials), "Lymphoma" (13 trials) and "Breast Cancer" (12 trials). Many other conditions were trialed in "Centre Hospitalier Universitaire de Quebec" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Universitaire de Quebec" are "Drug" (288 trials), "Other" (99 trials), "Biological" (97 trials), "Procedure" (86 trials) and "Radiation" (85 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (43 trials), "Placebo" (40 trials), "Laboratory Biomarker Analysis" (38 trials), "Cyclophosphamide" (31 trials) and "etoposide" (27 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Universitaire de Quebec" are 357 trials for "All" genders, 45 trials for "Female" genders and 31 trials for "Male" genders.

Currently, there are 158 active trials in "Centre Hospitalier Universitaire de Quebec". 1 are not yet recruiting, 84 are recruiting, 72 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 230 completed trials in Centre Hospitalier Universitaire de Quebec, 2 suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Universitaire de Quebec, 23 "Phase 1" clinical trials were conducted, 127 "Phase 2" clinical trials and 194 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 54 trials that are defined as “Not Applicable".